Evercore ISI raised the firm’s price target on Procter & Gamble to $183 from $180 and keeps an Outperform rating on the shares. Procter is “comping remarkably well” in the U.S., Europe and “enterprise” markets mainly in Latin America, which represent in aggregate 85% of sales and likely of profits, but the firm has adjusted its Q2 estimates to account for another round of China risk, the analyst tells investors in a post-earnings note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Netflix reports Q3 beat, CVS CEO Lynch steps down: Morning Buzz
- Procter & Gamble Highlights Market Trends and Regulations
- PG Earnings: Procter & Gamble Beats Earnings but Misses Sales Estimates in Q1
- Unusually active option classes on open October 18th
- Procter & Gamble says promotional market stable, slightly below pre-Covid levels